Amplifon SpAAMFPF 78 Debt-to-Equity is 1.66 as of Mar. 2026, which is 8% above its 10-year median of 1.53. GuruFocus rates AMFPF with a GF Score™ of 78/100 and a GF Value™ of $28.60 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 97 Medical Distribution companies, Amplifon SpA ranks worse than 87.63% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Amplifon SpA's Debt-to-Equity or its related term are showing as below:
AMFPF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.69 Med: 1.53 Max: 2.31
Current: 1.66
During the past 13 years, the highest Debt-to-Equity Ratio of Amplifon SpA was 2.31. The lowest was 0.69. And the median was 1.53.
AMFPF's Debt-to-Equity is ranked worse than 87.63% of 97
companies
in the Medical Distribution industry
Industry Median: 0.48
vs AMFPF: 1.66
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Amplifon SpA Debt-to-Equity Related Terms
Amplifon SpA Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Amplifon SpA's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Amplifon SpA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amplifon SpA Debt-to-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amplifon SpA's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Amplifon SpA's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amplifon SpA (AMFPF) has a Debt-to-Equity of 1.66 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Amplifon SpA and its competitors. This is near median its historical median of 1.53. Over the past decade, Amplifon SpA's Debt-to-Equity has ranged from 0.69 to 2.31. According to the industry distribution chart, Amplifon SpA ranks #85 out of 97 companies in the Medical Distribution industry, placing it in the top 87.6%.
Is Amplifon SpA's Debt-to-Equity too high?
Amplifon SpA's current Debt-to-Equity of 1.66 is near median its 10-year median of 1.53. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 2.31. The Medical Distribution industry median Debt-to-Equity is 0.48. Amplifon SpA's value of 1.66 is 245.8% above this industry median. Based on the distribution chart, Amplifon SpA ranks #85 out of 97 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Amplifon SpA has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Amplifon SpA's Debt-to-Equity compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Amplifon SpA ranks #85 out of 97 companies for Debt-to-Equity. This places Amplifon SpA in the lower half of its industry. The industry median Debt-to-Equity is 0.48. Amplifon SpA's value of 1.66 is 245.8% above this benchmark. Historically, Amplifon SpA's own Debt-to-Equity has ranged from 0.69 to 2.31 over the past decade. While the company's 10-year median is 1.53 vs. the industry median of 0.48, Amplifon SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Distribution company?
The median Debt-to-Equity among Medical Distribution companies is 0.48, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amplifon SpA's current Debt-to-Equity of 1.66 is 245.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Amplifon SpA and its competitors. For the Medical Distribution industry, the median Debt-to-Equity is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amplifon SpA's current Debt-to-Equity is 1.66, which is near median its own 10-year median of 1.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amplifon SpA stock overvalued right now?
Based on GuruFocus' analysis, Amplifon SpA (AMFPF) is currently considered Possible Value Trap. The stock's GF Value™ is $28.60, compared to a current price of $11.21 — trading 60.8% below its estimated fair value. The current Debt-to-Equity is 1.66, which is near median its 10-year median of 1.53 and 245.8% above the Medical Distribution industry median of 0.48. Amplifon SpA's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Amplifon SpA (AMFPF), the current Debt-to-Equity is 1.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amplifon SpA (AMFPF) Overvalued in 2026?
Based on GuruFocus' analysis, Amplifon SpA stock appears to be undervalued.
The current stock price of $11.21 is trading 60.8% below its estimated GF Value™ of $28.60.
GuruFocus considers Amplifon SpA to be Possible Value Trap.
Key valuation signals for AMFPF:
Debt-to-Equity: 1.66 (near median its 10-year median of 1.53)
GF Value™: $28.60 vs. price of $11.21 (60.8% below fair value)
Industry Position: 245.8% above the Medical Distribution median (#85 of 97)
No single metric tells the full story. See the AMFPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear.
78GF Score
Get the complete analysis for AMFPF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMFPF has been successfully added to your 
